A Dual Burden Dilemma: Navigating the Global Impact of Communicable and Non-Communicable Diseases and the Way Forward
DOI:
https://doi.org/10.55489/ijmr.123202412Keywords:
Non-Communicable Diseases, Dilemma, CDs and NCDs, Global Impact, Communicable DiseasesAbstract
The global burden of disease has shifted significantly, with communicable diseases (CDs) like HIV/AIDS, tuberculosis, and malaria increasingly intersecting with the rising prevalence of non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, and diabetes. This narrative review explores the dual burden posed by CDs and NCDs, emphasizing their interconnections, societal impacts, and regional disparities. While CDs continue to challenge healthcare systems in low- and middle-income countries, NCDs dominate global mortality, driven by aging populations, urbanization, and lifestyle changes. The review highlights how infectious agents contribute to chronic diseases, such as hepatitis B leading to liver cancer or COVID-19 exacerbating diabetes and cardiovascular risks. It underscores the necessity for integrated healthcare approaches that address both disease categories to reduce health inequities. Regional and demographic disparities, such as higher disease burdens in sub-Saharan Africa and Southeast Asia, are also discussed, along with their socio-economic drivers. Global efforts, including vaccination programs, lifestyle interventions, and sustainable health policies, are evaluated for their effectiveness and challenges. The review concludes with a call for innovative, equity-focused strategies to mitigate the dual burden and strengthen global health resilience.
References
1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222. DOI: https://doi.org/10.1016/S0140-6736(20)30925-9 PMid:33069326
2. World Health Organization. Noncommunicable Diseases Fact Sheet. WHO; 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
3. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: Burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):444-457. DOI: https://doi.org/10.1158/1055-9965.EPI-16-0858 PMid:28223433
4. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010;58(4):258-266. DOI: https://doi.org/10.1016/j.patbio.2009.11.001 PMid:20116937 PMCid:PMC2888709
5. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583-590. DOI: https://doi.org/10.1038/s41591-022-01689-3 PMid:35132265 PMCid:PMC8938267
6. Nugent R. A chronology of global assistance funding for NCDs: 1990-2019. Glob Health. 2020;16:31.
7. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet. 2012;380(9846):1011-1029. DOI: https://doi.org/10.1016/S0140-6736(12)61228-8 PMid:22964159
8. World Health Organization. Communicable diseases. WHO; 2023. Available at: https://www.who.int/
9. UNAIDS. Global HIV & AIDS statistics - Fact sheet. UNAIDS; 2023. Available at: https://www.unaids.org
10. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS by the Numbers 2022. Geneva: UNAIDS; 2022.
11. World Health Organization. Global tuberculosis report 2022. Geneva: WHO; 2022.
12. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240-2246. DOI: https://doi.org/10.1016/j.socscimed.2009.03.041 PMid:19394122
13. World Health Organization. World malaria report 2022. Geneva: WHO; 2022.
14. White NJ, Pukrittayakamee S, Hien TT, et al. Malaria. Lancet. 2014;383(9918):723-735. DOI: https://doi.org/10.1016/S0140-6736(13)60024-0 PMid:23953767
15. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/
16. The Lancet COVID-19 Commission. Lessons for the future from the COVID-19 pandemic. Lancet. 2023;401(10385):1-3. DOI: https://doi.org/10.1016/S0140-6736(23)00848-6 PMid:37120273
17. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg. 2001;64(1_suppl):85-96. DOI: https://doi.org/10.4269/ajtmh.2001.64.85 PMid:11425181
18. O'Donnell J, Johnson M, Longo F. COVID-19 and its impact on routine immunization: Challenges and re-sponses. Vaccine. 2023;41(10):1442-1450.
19. Goffman E. Stigma: Notes on the Management of Spoiled Identity. Simon and Schuster; 2009.
20. Greenwood B. The contribution of vaccination to global health: Past, present and future. Phil Trans R Soc B. 2014;369(1645):20130433. DOI: https://doi.org/10.1098/rstb.2013.0433 PMid:24821919 PMCid:PMC4024226
21. Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death, and inequity worldwide. Bull World Health Organ. 2008;86(2):140-146. DOI: https://doi.org/10.2471/BLT.07.040089 PMid:18297169 PMCid:PMC2647387
22. Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa be-tween 2000 and 2015. Nature. 2015;526(7572):207-211. DOI: https://doi.org/10.1038/nature15535 PMid:26375008 PMCid:PMC4820050
23. The Global Fund. Annual report 2022. Geneva: The Global Fund; 2022.
24. World Health Organization. Noncommunicable diseases. WHO; 2023. Available at: https://www.who.int
25. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territo-ries, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-1249. DOI: https://doi.org/10.1016/S0140-6736(20)30752-2 PMid:33069327
26. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lan-cet. 2011;377(9775):1438-1447. DOI: https://doi.org/10.1016/S0140-6736(11)60393-0 PMid:21474174
27. Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336-1343. DOI: https://doi.org/10.1056/NEJMra1109345 PMid:24088093
28. World Health Organization. Cardiovascular diseases (CVDs) Fact Sheet. WHO; 2023. Available at: https://www.who.int
29. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://doi.org/10.3322/caac.21660 PMid:33538338
30. Prager GW, Braga S, Bystricky B, et al. Global cancer control: Responding to the growing burden, rising costs, and inequalities in access. ESMO Open. 2018;3(2):e000285. https://doi.org/10.1136/esmoopen-2017-000285 PMid:29464109 PMCid:PMC5812392
31. International Diabetes Federation. IDF Diabetes Atlas 10th Edition. Brussels, Belgium: IDF; 2021.
32. GBD Chronic Respiratory Disease Collaborators. Global burden of chronic respiratory diseases and their risk factors, 1990-2015. Lancet Respir Med. 2017;5(6):487-507.
33. United Nations. World Urbanization Prospects: The 2018 Revision. New York: UN DESA; 2018.
34. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A pro-spective cohort study. Lancet. 2020;395(10226):795-808. https://doi.org/10.1016/S0140-6736(19)32008-2 PMid:31492503
35. Bloom DE, Chatterji S, Kowal P, et al. Macroeconomic implications of population ageing and selected policy responses. Lancet. 2015;385(9968):649-657. DOI: https://doi.org/10.1016/S0140-6736(14)61464-1 PMid:25468167
36. Ezzati M, Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med. 2013;369(10):954-964. DOI: https://doi.org/10.1056/NEJMra1203528 PMid:24004122
37. Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448-457. DOI: https://doi.org/10.1056/NEJMra1201534 PMid:23902484
38. Chen S, Kuhn M, Prettner K, Bloom DE. Noncommunicable diseases attributable to tobacco use in China: Macroeconomic burden and policy implications. PLoS One. 2021;16(4):e0249271.
39. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum; 2011.
40. World Bank. The Growing Burden of Non-Communicable Diseases. Washington, DC: World Bank; 2022.
41. Frieden TR. A framework for public health action: The health impact pyramid. Am J Public Health. 2010;100(4):590-595. DOI: https://doi.org/10.2105/AJPH.2009.185652 PMid:20167880 PMCid:PMC2836340
42. WHO Global Health Observatory. NCD Risk Factors. Available at: https://www.who.int/data/gho
43. Bauman AE, Petersen CB, Blond K, Rangul V, Hardy LL. The descriptive epidemiology of sedentary be-havior. Springer. 2018;9:45-66.
44. Mozaffarian D, Afshin A, Benowitz NL, et al. Population approaches to improve diet, physical activity, and smoking habits: A scientific statement from the American Heart Association. Circulation. 2012;126(12):1514-1563. DOI: https://doi.org/10.1161/CIR.0b013e318260a20b PMid:22907934 PMCid:PMC3881293
45. World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2030. Geneva: WHO; 2013.
46. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(S1):4-13. DOI: https://doi.org/10.1002/hep.31288 PMid:32319693 PMCid:PMC7577946
47. World Health Organization. Hepatitis B. WHO; 2023. Available at: https://www.who.int
48. Bruni L, Albero G, Serrano B, et al. Human Papillomavirus and Related Diseases Report. Barcelona: ICO/IARC Information Centre on HPV and Cancer; 2021.
49. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2020: A worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203. DOI: https://doi.org/10.1016/S2214-109X(19)30482-6 PMid:31812369
50. Plummer M, de Martel C, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter py-lori. Int J Cancer. 2015;136(2):487-490. DOI: https://doi.org/10.1002/ijc.28999 PMid:24889903
51. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525-1533. DOI: https://doi.org/10.1016/S0140-6736(13)61809-7 PMid:24152939
52. Feinstein MJ, Hsue PY, Benjamin LA, et al. Characteristics, prevention, and management of cardiovascu-lar disease in people living with HIV: A scientific statement from the American Heart Association. Cir-culation. 2019;140(2):98-124. DOI: https://doi.org/10.1161/CIR.0000000000000695 PMid:31154814 PMCid:PMC7993364
53. Rabkin M, Nishtar S. Scaling up chronic care systems: Leveraging HIV programs to support noncom-municable disease services. J Acquir Immune Defic Syndr. 2011;57(Suppl 2):S87-S90. DOI: https://doi.org/10.1097/QAI.0b013e31821db92a PMid:21857304
54. World Health Organization. Integrated health services for HIV and NCDs. WHO; 2022. Available at: https://www.who.int
55. Su TH, Liu CJ, Tseng TC, et al. Long-term effects of hepatitis B immunoglobulin and nucleoside analogs on prevention of mother-to-child transmission of HBV. Clin Gastroenterol Hepatol. 2020;18(13):2875-2882.
56. Weiss MG, Ramakrishna J. Stigma interventions and research for international health. Lancet. 2006;367(9509):536-538. DOI: https://doi.org/10.1016/S0140-6736(06)68189-0
57. PMid:16473134
58. Triant VA. HIV infection and coronary heart disease: An intersection of epidemics. J Infect Dis. 2012;205(Suppl 3):S355-S361. DOI: https://doi.org/10.1093/infdis/jis195 PMid:22577208 PMCid:PMC3349293
59. Sankaranarayanan R, Basu P, Kaur P, et al. Current status of human papillomavirus vaccination in In-dia's cervical cancer prevention efforts. Lancet Oncol. 2019;20(11):e637-e644. DOI: https://doi.org/10.1016/S1470-2045(19)30531-5 PMid:31674322
60. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-550. DOI: https://doi.org/10.1016/S2213-8587(20)30152-2 PMid:32334646
61. Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2023;11(5):356-368. DOI: https://doi.org/10.1016/S2213-8587(22)00355-2 PMid:36623520
62. Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health. 2014;104(Suppl 4):S517-S519. DOI: https://doi.org/10.2105/AJPH.2014.302200 PMid:25100411 PMCid:PMC4151898
63. World Health Organization. Malaria Fact Sheet. WHO; 2023. Available at: https://www.who.int
64. Snow RW, Sartorius B, Kyalo D, et al. The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900. Nature. 2017;550(7677):515-518. DOI: https://doi.org/10.1038/nature24059 PMid:29019978 PMCid:PMC5660624
65. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lan-cet. 2011;377(9775):1438-1447. DOI: https://doi.org/10.1016/S0140-6736(11)60393-0 PMid:21474174
66. African Union. Africa's Health Status 2023. Addis Ababa: AU; 2023.
67. WHO Regional Office for Southeast Asia. Health situation in the South-East Asia Region 2022. New Del-hi: WHO SEARO; 2022.
68. Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: Current epidemiology and future di-rections. Circulation. 2016;133(16):1605-1620. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.008729 PMid:27142605
69. OECD. Health at a Glance 2023. Paris: OECD; 2023.
70. UNICEF. Levels & Trends in Child Mortality 2022. New York: UNICEF; 2022.
71. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427-451. DOI: https://doi.org/10.1016/S0140-6736(13)60937-X PMid:23746772
72. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults 1980-2013: A systematic analysis. Lancet. 2014;384(9945):766-781. DOI: https://doi.org/10.1016/S0140-6736(14)60460-8 PMid:24880830
73. Lobstein T, Jackson-Leach R, Moodie ML, et al. Child and adolescent obesity: Part of a bigger picture. Lancet. 2015;385(9986):2510-2520. DOI: https://doi.org/10.1016/S0140-6736(14)61746-3 PMid:25703114
74. WHO. Global strategy and action plan on ageing and health 2020. Geneva: WHO; 2020.
75. Beard JR, Officer A, de Carvalho IA, et al. The World report on ageing and health: A policy framework for healthy ageing. Lancet. 2016;387(10033):2145-2154. DOI: https://doi.org/10.1016/S0140-6736(15)00516-4 PMid:26520231
76. Centers for Disease Control and Prevention (CDC). Flu and Older Adults. CDC; 2023. Available at: https://www.cdc.gov
77. John Hopkins Medicine. COVID-19 and Older Adults. Available at: https://www.hopkinsmedicine.org
78. WHO. Air pollution and child health: Prescribing clean air. Geneva: WHO; 2018.
79. Gracey M, King M. Indigenous health part 1: Determinants and disease patterns. Lancet. 2009;374(9683):65-75. DOI: https://doi.org/10.1016/S0140-6736(09)60914-4 PMid:19577695
80. Anderson I, Robson B, Connolly M, et al. Indigenous and tribal peoples' health (The Lancet-Lowitja In-stitute Global Collaboration): A population study. Lancet. 2016;388(10040):131-157. DOI: https://doi.org/10.1016/S0140-6736(16)00345-7 PMid:27108232
81. UNAIDS. Addressing HIV stigma and discrimination in healthcare settings. UNAIDS; 2022.
82. Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13-24. DOI: https://doi.org/10.1016/S0277-9536(02)00304-0 PMid:12753813
83. Sen G, Östlin P. Gender inequity in health: Why it exists and how we can change it. Glob Public Health. 2008;3(Suppl 1):1-12. DOI: https://doi.org/10.1080/17441690801900795 PMid:19288339
84. Watts N, Amann M, Arnell N, et al. The 2020 report of The Lancet Countdown on health and climate change: Responding to converging crises. Lancet. 2021;397(10269):129-170. DOI: https://doi.org/10.1016/S0140-6736(20)32290-X PMid:33278353
85. Haines A, Ebi K. The imperative for climate action to protect health. N Engl J Med. 2019;380(3):263-273. DOI: https://doi.org/10.1056/NEJMra1807873 PMid:30650330
86. Patz JA, Frumkin H, Holloway T, Vimont DJ, Haines A. Climate change: Challenges and opportunities for global health. JAMA. 2014;312(15):1565-1580. DOI: https://doi.org/10.1001/jama.2014.13186 PMid:25244362 PMCid:PMC6108836
87. World Bank. Universal health coverage: Addressing challenges in LMICs. Washington DC: World Bank; 2022.
88. WHO. Global spending on health 2023. Geneva: WHO; 2023.
89. Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from cata-strophic health expenditures. Health Aff. 2007;26(4):972-983. DOI: https://doi.org/10.1377/hlthaff.26.4.972 PMid:17630440
90. Horton R. Offline: Planetary health is about more than disease. Lancet. 2021;398(10308):881. DOI: https://doi.org/10.1016/S0140-6736(21)02220-0 PMid:34627481
91. Global Vaccine Action Plan Secretariat. Decade of Vaccines Report. Geneva: WHO; 2020.
92. Polio Eradication Initiative. Progress towards polio eradication 2023. Available at: https://polioeradication.org
93. WHO. The End TB Strategy. Geneva: WHO; 2015. Available at: https://www.who.int
94. United Nations. Sustainable Development Goals 2015. Available at: https://sdgs.un.org
95. Sachs JD, Schmidt-Traub G, Kroll C, Lafortune G, Fuller G. Sustainable Development Report 2023. Cam-bridge: Cambridge University Press; 2023. DOI: https://doi.org/10.1017/9781009210058
96. Prüss-Ustün A, Wolf J, Corvalán C, et al. Preventing disease through healthy environments: A global as-sessment of the burden of disease from environmental risks. Geneva: WHO; 2016.
97. The Global Fund. Results report 2023. Geneva: The Global Fund; 2023.
98. Gavi, the Vaccine Alliance. Annual Progress Report 2023. Available at: https://www.gavi.org
99. Jit M, Hutubessy R, Png ME, et al. The broader economic impact of vaccination: Reviewing and apprais-ing the strength of evidence. BMC Med. 2015;13(1):209. DOI: https://doi.org/10.1186/s12916-015-0446-9 PMid:26335923 PMCid:PMC4558933
100. WHO. ACT-Accelerator Strategic Review 2022. Geneva: WHO; 2022.
101. Berkley S. COVAX explained: Making COVID-19 vaccines accessible to the world. Gavi; 2022. Available at: https://www.gavi.org
102. Rangan M, Schanz M, Rishty M. Using health impact bonds to achieve SDGs. World Econ Forum White Paper. 2021.
103. WHO. Global Health Observatory. Available at: https://www.who.int
104. Freifeld CC, Mandl KD, Reis BY, Brownstein JS. HealthMap: Global infectious disease monitoring through online media. N Engl J Med. 2008;358(21):2156-2158.
105. Hadfield J, Megill C, Bell SM, et al. Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121-4123. DOI: https://doi.org/10.1093/bioinformatics/bty407 PMid:29790939 PMCid:PMC6247931
106. Jackson NA, Kester KE, Casimiro D, Gurunathan S, DeRosa F. The promise of mRNA vaccines: A biotech-nology breakthrough. Nat Rev Drug Discov. 2020;19(12):845-862.
107. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines: Emerging technology for infectious dis-eases and beyond. Nat Rev Drug Discov. 2018;17(4):261-279. DOI: https://doi.org/10.1038/nrd.2017.243 PMid:29326426 PMCid:PMC5906799
108. WHO. Integrated Vector Management Strategy. Geneva: WHO; 2015.
109. Lawn JE, Kerber K, Enweronu-Laryea C, Massee Bateman O. Newborn survival in low-resource set-tings-are we delivering? BJOG. 2009;116(1):49-59. DOI: https://doi.org/10.1111/j.1471-0528.2009.02328.x PMid:19740173
110. Tangcharoensathien V, Mills A, Palu T. Accelerating health equity: The key role of universal health cov-erage in the Sustainable Development Goals. BMC Med. 2015;13:101. DOI: https://doi.org/10.1186/s12916-015-0342-3 PMid:25925656 PMCid:PMC4415234
111. Binagwaho A, Scott KW. Improving the world's health through the post-2015 development agenda: Perspectives from Rwanda. Int J Health Policy Manag. 2015;4(4):203-205. DOI: https://doi.org/10.15171/ijhpm.2015.46 PMid:25844381 PMCid:PMC4380561
112. Jain KK. Personalized medicine for cancer: From drug development into clinical practice. Expert Opin Pharmacother. 2017;18(18):1701-170
113. Chatterjee S, Suryawanshi S, Patel S, et al. Healthcare access and inequality in low-resource settings: A global perspective. Lancet Global Health. 2020;8(7):e931-e940.
114. WHO. Universal health coverage: The path to achieving the SDGs. Geneva: WHO; 2017.
115. Horton R. Offline: Global health inequity. Lancet. 2020;396(10249):1491. DOI: https://doi.org/10.1016/S0140-6736(20)32668-4 PMid:33308454
116. OECD. The looming challenge of non-communicable diseases: A reality check. OECD Health Working Pa-pers. 2022.
117. Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: A worldwide challenge. Lancet. 2016;387(10014):1723-1732. DOI: https://doi.org/10.1016/S0140-6736(15)00474-2 PMid:26603918
118. WHO. Global Action Plan on Antimicrobial Resistance. Geneva: WHO; 2015.
119. WHO. Antimicrobial Resistance: Global Report on Surveillance. Geneva: WHO; 2014.
120. O'Neill J. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. Review on An-timicrobial Resistance. 2014.
121. Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm Ther. 2015;40(4):277-283.
122. WHO. Global Status Report on Noncommunicable Diseases 2014. Geneva: WHO; 2014.
123. Popkin BM, Reardon T, Henson S. The global nutrition transition: The pandemic of obesity in develop-ing countries. Nut Rev. 2020;71(1):1-24.
124. Hawkes C, Ruel M, Salm L, et al. Global food systems and health: Building a more sustainable food future. Lancet. 2018;392(10158):331-350.
125. Prentice AM, Jebb SA. Obesity in developing countries: A growing concern. Int J Obes. 2004;28(3):113-116.
126. World Population Ageing 2020. United Nations Department of Economic and Social Affairs. Population Division, 2020.
127. World Health Organization. Tuberculosis country profiles. Geneva: WHO; 2021. Available at: https://www.who.int
128. Murray CJ, Aravkin AY, Zheng P, et al. Global burden of disease study 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222. DOI: https://doi.org/10.1016/S0140-6736(20)32340-0 PMid:33275908
129. Narayan KMV, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabe-tes Care. 2007;30(6):1562-1566. DOI: https://doi.org/10.2337/dc06-2544 PMid:17372155
130. Dash S, Chatterjee S. Integrated health information systems and the future of disease surveillance. J Health Inf Manage. 2018;22(2):63-72.
131. Caraballo L, Martinelli L, Finkelstein A, et al. Big data in healthcare: Opportunities and challenges. J Med Syst. 2020;44(1):21-29.
132. Patz JA, Campbell-Lendrum D, Holloway T, et al. Impact of regional climate change on human health. Na-ture. 2005;438(7066):310-317. DOI: https://doi.org/10.1038/nature04188 PMid:16292302
133. WHO. Malaria and Climate Change: The Role of Weather and Climate. Geneva: WHO; 2020.
134. Haines A, Kovats RS, Campbell-Lendrum D, et al. Climate change and human health: Impacts, vulnerabil-ity, and public health. Public Health. 2006;120(7):585-596. DOI: https://doi.org/10.1016/j.puhe.2006.01.002 PMid:16542689
135. Gisselquist D. Emerging infectious diseases: Global health and the threats from zoonoses. J Global Health. 2014;4(2):210-222.
136. Fisher-Hoch SP, Vinetz JM. Emerging zoonotic diseases. Am J Public Health. 2014;104(8):1455-1461.
137. Lewis KD, Butler WR. Antimicrobial resistance and emerging infectious diseases: A call for greater global health surveillance. Epidemiol Infect. 2020;148:1-3.
138. WHO. Post-COVID-19 Syndrome. Geneva: WHO; 2022.
Downloads
Published
How to Cite
Issue
Section
License
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
